| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 04:15 | BIOXYNE LIMITED - On Track To Report Clinical Trial Results In June | | - | wotnews |
| 03:45 | CSL New issue announcement | | - | wotnews |
| 00:01 | XFRA DIVIDEND INFORMATION - 29.05.2012 - 2 | | 101 | Xetra Newsboard |
| FOLGENDE WERTPAPIERE WERDEN AM 28.05.2012 CUM DIVIDENDE UND AM 29.05.2012
EX DIVIDENDE GEHANDELT.
THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 28.05.2012. THE
EX-DIVIDEND DAY WILL BE 29.05.2012.
...
Mehr lesen zu:
XFRA DIVIDEND INFORMATION - 29.05.2012 - 2 | |
| 27.05.
| 3 Reasons To Buy Onyx Pharmaceuticals | | 1 | Seeking Alpha |
| 27.05.
| 3SBio Inc. To Present at the DB Access Asia Conference 2012 | | 94 | PR Newswire |
| SHENYANG, China, May 27, 2012 /PRNewswire-Asia/-- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing...
Mehr lesen zu:
3SBio Inc. To Present at the DB Access Asia Conference 2012 | |
| 27.05.
| Durect is Among the Companies in the Pharmaceuticals Industry With the Highest Earnings Yield | | - | SmarTrend |
| 26.05.
| Sanofi, Regeneron Publish Results For Lipid-Lowering PCSK9 Antibody In Lancet | | 240 | AFX News |
| PARIS (dpa-AFX) - Sanofi (SNY) and Regeneron Pharmaceuticals Inc. (REGN)
announced additional positive results from a Phase 2 trial of SAR236553/REGN727
(Study 1003, NTC01266876) in patients...
Mehr lesen zu:
Sanofi, Regeneron Publish Results For Lipid-Lowering PCSK9 Antibody In Lancet | |
| 26.05.
| Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet | | 166 | PR Newswire |
| PARIS and TARRYTOWN, New York, May 26, 2012 /PRNewswire/ --
Global Phase 3 program of SAR236553/REGN727 to be initiated in June across multiple patient populations
Sanofi (EURONEXT: SAN and NYSE:...
Mehr lesen zu:
Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet | |
| 26.05.
| Amgen has the Highest Level of Cash in the Biotechnology Industry | | 1 | SmarTrend |
| 26.05.
| Intercell will Möglichkeiten für neue Partnerschaften vergrößern | | 14 | boerse-express.com |
| 26.05.
| Statements zu SBO, voest, Intercell, Raiffeisen, Versicherer, Immo's, etc. | | 16 | boerse-express.com |
| 26.05.
| Dendreon Announces Webcast Presentations at Upcoming Conferences | | 76 | Business Wire |
| May 25, 2012--Dendreon Corporation (NASDAQ:DNDN) today announced
that management will present at the following conferences:
Jefferies 2012 Global...
Mehr lesen zu:
Dendreon Announces Webcast Presentations at Upcoming Conferences | |
| 26.05.
| Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In AEterna Zentaris Inc. To Contact The Firm | | 72 | PR Newswire |
| NEW YORK, May 25, 2012 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at AEterna Zentaris Inc. ("AEterna" or...
Mehr lesen zu:
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In AEterna Zentaris Inc. To Contact The Firm | |
| 25.05.
| WILEX AG berichtet über Hauptversammlung 2012 | | 131 | dpa-AFX |
| WILEX AG berichtet über Hauptversammlung 2012
DGAP-News: WILEX AG / Schlagwort(e): Hauptversammlung WILEX AG
berichtet über Hauptversammlung 2012
25.05.2012 / 23:51
--------------------------------------------------------------------
-
PRESSEMITTEILUNG
WILEX...
Mehr lesen zu:
WILEX AG berichtet über Hauptversammlung 2012 | |
| 25.05.
| GenVec Reports Inducement Award | | 70 | PR Newswire |
| GAITHERSBURG, Md., May 25, 2012 /PRNewswire/ --GenVec, Inc. (NASDAQ: GNVC) announced today that on May 23, 2012 it granted an option to purchase shares of its common stock to Cynthia...
Mehr lesen zu:
GenVec Reports Inducement Award | |
| 25.05.
| Possible Bullish Inside Day Candle Pattern Detected for Cell Therapeutics | | 2 | SmarTrend |
| 25.05.
| Can Seattle Genetics Break Through Looming Resistance? | | - | Schaeffer's Research |
| 25.05.
| Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc. | | 53 | Business Wire |
| Cannabis Science, Inc. (OTCBB: CBIS), a pioneering U.S. biotech company
developing pharmaceutical cannabis (marijuana) products, is pleased to
provide insight on the upcoming...
Mehr lesen zu:
Cannabis Science Gets Set to Release "Phytiva" Its Newest Brand of Over-the-Counter Skin and Nutraceutical Product Lines Through its Newest Venture Phytiva Pharmaceuticals Inc. | |
| 25.05.
| Human Genome Shareholders Should Not Get Greedy | | 10 | Seeking Alpha |
| 25.05.
| Gen-Probe Remains Neutral | | - | Zacks |
